Silesian Centre for Heart Diseases
19
4
4
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 19 trials
100.0%
+13.5% vs industry average
11%
2 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Impact of Eccentric Training in Hypoxia With Creatine on Metabolic Control and VO2max in Patients With Type 1 Diabetes
Role: lead
Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation
Role: collaborator
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Role: lead
Impact of Predilatation Between Self-expanding Valves
Role: collaborator
Cerebral Protection in Transcatheter Left Atrial Appendage Occlusion
Role: lead
Silesian Registry of Out-of-Hospital Cardiac Arrests
Role: lead
Physical Exercise in Normobaric Hypoxia and Normoxia in Type 1 Diabetic Patients
Role: lead
The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications
Role: lead
Predictors of Pulmonary Hypertension in Patients With Advanced Lung Diseases
Role: lead
Day-care Unit for Patients With Refractory Heart Failure
Role: lead
Stable Angina Management and Treatment
Role: lead
Contemporary Modalities in Treatment of Heart Failure
Role: lead
Metal Allergy In-Stent Restenosis Study
Role: lead
Remote Supervision to Decrease Hospitalization Rate
Role: lead
Cardiovascular Diseases in the Silesian Region in Poland.
Role: lead
Hyperlipidemia Therapy TERCET Zabrze Registry
Role: lead
Studies Investigating Co-morbidities Aggravating Heart Failure
Role: collaborator
Efficiency Study of Triple-Site Cardiac Resynchronization in Patients With Heart Failure
Role: lead
Safety and Efficacy Study of Hybrid Revascularization in Multivessel Coronary Artery Disease
Role: lead
All 19 trials loaded